The Government of Alberta will launch a dual-practice surgical care model in September 2026, allowing eligible physicians to perform both publicly funded procedures and privately paid surgeries in accredited facilities. The framework will initially cover selected orthopedic, ophthalmology, gynecological, ear, nose and throat, dermatology, plastic surgery and minimally invasive general surgery procedures, while emergency care, cancer surgery and other life-saving services will remain exclusively within the publicly funded system.
The significance of the reform extends well beyond giving some patients an additional payment option. Alberta is attempting to create a regulated market in which the same specialist workforce can operate across public and private channels without reducing publicly available care. Whether that balance can be maintained will depend on workforce rules, operating room allocation, pricing controls, clinical governance and transparent performance reporting.
Why Alberta’s dual-practice model represents a structural healthcare change rather than a simple capacity expansion
Dual practice allows participating specialists to continue treating patients through the Alberta Health Care Insurance Plan while separately performing eligible procedures for patients who pay privately or obtain coverage through an employer or insurance arrangement. Physicians may also remain entirely within either the public or private system, meaning participation in the mixed model will not be compulsory.
This represents a more consequential change than contracting private surgical facilities to complete publicly funded procedures. Alberta already uses chartered surgical facilities to deliver selected publicly insured operations. Under the new framework, however, a physician could serve publicly funded patients and private-paying patients within the same broader provincial healthcare market.
The reform therefore changes both the financing and incentive structure surrounding surgical access. A private provider will no longer depend exclusively on government-funded procedure volumes. It could generate revenue directly from patients, employers or insurers, potentially supporting investment in facilities, operating room equipment, digital scheduling systems and specialist recruitment.
The commercial opportunity is nevertheless tied to a limited range of elective procedures. Hip and knee replacements, cataract surgery, hernia repair and selected gynecological or ear, nose and throat operations are relatively suitable for standardized pathways and planned scheduling. These procedures can often be supported by repeatable clinical protocols, established medical device supply chains and predictable postoperative care requirements.

That does not make capacity expansion automatic. Surgical output depends on anesthesiologists, nurses, surgical assistants, sterilization staff, diagnostic services, rehabilitation capacity and postoperative beds, not merely on the availability of a surgeon or an unused operating room. Private facilities could add physical capacity while competing with public hospitals for the same constrained workforce.
Why the unresolved public-service requirement could determine whether wait times improve or deteriorate
Alberta intends to require dual-practice physicians to complete a minimum amount of work in the public system before they can provide privately paid surgery. Acute Care Alberta will establish the requirement, but the number of hours, the method of measurement and the consequences of non-compliance have not yet been finalized.
This is the most important unresolved component of the policy. A low threshold could allow specialists to direct a meaningful share of their clinical time toward better-paying private procedures. A rigid or excessively high threshold could make participation commercially unattractive and prevent the private market from generating additional capacity.
Hours alone may also be an inadequate measure. A physician could satisfy an hourly requirement while performing fewer complex public procedures, selecting shorter cases or completing work in locations that do not address the most severe backlogs. Regulators may need to consider procedure volumes, case complexity, cancellations, geographic coverage and specialty-specific demand rather than relying on a single time-based standard.
The sequencing of public and private cases will require particular scrutiny. Physicians advising patients about expected public wait times may also be able to offer a faster privately paid route. That creates a potential conflict between the clinical role of helping a patient navigate care and the commercial opportunity generated when the patient chooses private treatment.
A credible framework will require separation between public wait-list management and private patient acquisition. Referral pathways, price disclosures, informed consent documents and communications about expected waiting periods will need to make clear that choosing public care will not reduce a patient’s clinical priority or future access.
How private surgical growth could affect hospitals, insurers and medical device manufacturers
The reform creates a potential growth market for independent surgical operators and specialist-led clinics. Accredited facilities could increase procedure volumes, extend operating hours and invest in capacity if sufficient private demand emerges. Hospitals may also participate where underused operating rooms can be made available without displacing publicly funded activity.
Using hospital infrastructure for privately financed procedures introduces difficult cost-allocation questions. Operating room time, utilities, sterilization, recovery areas, pharmacy support, medical records, emergency backup and infection-control systems all carry costs. Clear accounting will be required to prevent public funding from unintentionally subsidizing private services.
Insurers and employers could also become more influential purchasers of medically necessary care. Workplace health plans may eventually offer faster access to selected surgeries as an employee benefit, particularly for roles in which prolonged musculoskeletal disability creates high absence or productivity costs.
Private coverage could initially remain concentrated among larger employers and higher-income households. Smaller employers may find surgical benefits too expensive, while individual policies could carry exclusions, waiting periods or premiums that place them beyond the reach of many residents. The resulting market may therefore improve access for a defined insured population without materially changing access for people who remain dependent on the public system.
Medical device manufacturers could benefit if the model produces genuinely additional procedure volumes. Orthopedic implants, cataract lenses, endoscopic instruments, surgical visualization systems, anesthesia equipment and minimally invasive surgery products may see incremental demand from expanding facilities.
However, a shift in where procedures are performed does not necessarily represent net market growth. If privately financed operations merely replace surgeries that would eventually have been completed publicly, demand may move between purchasing channels rather than increase. Manufacturers will also face more fragmented procurement, as individual facilities may negotiate separately instead of purchasing through larger public contracts.
Why comparisons with European and Australian health systems require greater caution
Alberta has pointed to countries including the United Kingdom, France, Germany, Denmark, Sweden, the Netherlands and Australia as examples of systems that combine universal coverage with mixed public and private practice. These comparisons establish that dual practice is not inherently limited to a United States-style healthcare system.
They do not prove that the Alberta model will achieve the same outcomes. International systems differ in physician employment contracts, hospital financing, private insurance regulation, reimbursement rates, waiting-list guarantees and the degree to which public and private activity is separated.
Some countries use private insurance as a supplementary option, while others rely on statutory insurance funds or tightly regulated purchasing arrangements. Several have national workforce planning mechanisms and hospital payment systems that do not have direct Canadian equivalents.
International evidence on dual practice is also mixed. Properly governed models can retain specialists, use facilities outside normal public operating hours and give physicians incentives to remain within the jurisdiction. Poorly governed models can encourage self-referral, shift clinicians toward private patients and lengthen public waiting periods.
Alberta’s results will therefore depend less on whether another country permits dual practice and more on the details of its own regulatory controls. The province will need to demonstrate that private expansion is adding staff, operating hours and completed procedures rather than reallocating existing public resources.
How the Canada Health Act dispute could create regulatory and financial uncertainty
Alberta maintains that its model complies with the Canada Health Act because privately paid services will be delivered through physicians operating under a distinct participation status. The province also states that medically necessary care will continue to be available without out-of-pocket payment through the public system.
The unresolved legal issue is whether permitting patients to pay for faster access to a medically necessary service conflicts with federal accessibility requirements. The Canada Health Act requires insured hospital and physician services to be available on uniform terms without patient charges, while provinces retain considerable authority over healthcare administration and physician participation rules.
The disagreement may ultimately focus on how physicians are classified, whether the same procedure remains an insured service when provided privately and whether the private pathway affects reasonable public access. Federal enforcement could include deductions from healthcare transfers when prohibited extra billing or user charges are identified.
Legal uncertainty could slow investment by surgical operators and insurers. Facilities will need confidence that the payment model will remain permitted before committing capital to operating rooms, staffing and specialized equipment. Physicians will similarly need clarity on billing, professional liability, record integration and whether private participation could affect their public reimbursement status.
The policy may therefore enter operation before its long-term legal position is fully settled. That creates implementation risk even if the first group of approved physicians begins dual practice as planned.
What regulators must measure to determine whether Alberta’s reform is working
The success of the model cannot be judged simply by counting privately paid surgeries. A higher private procedure total may show that a market exists, but it does not establish that public access has improved.
Regulators will need to publish procedure-specific public wait times, public surgical volumes, physician hours, operating room utilization and cancellation rates before and after implementation. Results should be separated by specialty, region, facility and patient priority so that deterioration in one part of the system is not concealed by province-wide averages.
Clinical quality must receive equal attention. Private and public procedures should be measured using comparable indicators for complications, infections, emergency transfers, revisions, readmissions and patient-reported outcomes. Integrated medical records are an important safeguard, but data submission alone will not ensure that fragmented care pathways remain safe.
Workforce movement may become the earliest warning signal. Changes in nursing vacancies, anesthesia coverage, public hospital overtime, specialist availability and rehabilitation delays could reveal whether the private market is expanding total capacity or redistributing existing personnel.
Affordability and patient behaviour will also matter. Alberta should disclose typical private prices, insurance coverage patterns and the proportion of patients referred to private treatment by physicians who also provide the paid service. Transparent reporting would make it easier to identify inappropriate steering or widening access inequalities.
The September 2026 launch will begin an experiment whose consequences will be determined by implementation rather than political positioning. Dual practice could create additional surgical capacity if new investment, longer operating hours and stronger physician retention translate into more total procedures. It could also intensify workforce shortages and weaken public access if private revenue draws scarce personnel away from publicly funded care.
For healthcare providers, insurers and medical device manufacturers, Alberta is opening a potentially important commercial channel. For regulators and clinicians, the priority will be proving that commercial expansion does not come at the expense of equitable access, clinical quality or the sustainability of the public system.